These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26344591)

  • 21. Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives as Potential Angiogenesis Inhibitors.
    Xue WJ; Du JY; Deng YH; Yan ZH; Liu JP; Liu Y; Sun LP
    Chem Biodivers; 2019 Aug; 16(8):e1900232. PubMed ID: 31287621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel VEGFR-2 inhibitors with an N-acylhydrazone scaffold.
    Pauli FP; Martins JR; Paschoalin T; Ionta M; Barbosa MLC; Barreiro EJ
    Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000130. PubMed ID: 32667721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signaling.
    Huang Y; Zhang Y; Li J; Ma X; Hu M; Yang Y; Gao S
    Anticancer Drugs; 2019 Jun; 30(5):508-516. PubMed ID: 30531369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents.
    Aziz MA; Serya RA; Lasheen DS; Abdel-Aziz AK; Esmat A; Mansour AM; Singab AN; Abouzid KA
    Sci Rep; 2016 Apr; 6():24460. PubMed ID: 27080011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors.
    Kuo GH; Wang A; Emanuel S; Deangelis A; Zhang R; Connolly PJ; Murray WV; Gruninger RH; Sechler J; Fuentes-Pesquera A; Johnson D; Middleton SA; Jolliffe L; Chen X
    J Med Chem; 2005 Mar; 48(6):1886-900. PubMed ID: 15771433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of novel oxazolo[5,4-d]pyrimidines as potent VEGFR-2 inhibitors.
    Deng YH; Xu D; Su YX; Cheng YJ; Yang YL; Wang XY; Zhang J; You QD; Sun LP
    Chem Biodivers; 2015 Apr; 12(4):528-37. PubMed ID: 25879498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of 1-(substituted)-3-prop-2-ynylureas as antiangiogenic agents.
    Sanphanya K; Wattanapitayakul SK; Prangsaengtong O; Jo M; Koizumi K; Shibahara N; Priprem A; Fokin VV; Vajragupta O
    Bioorg Med Chem Lett; 2012 Apr; 22(8):3001-5. PubMed ID: 22414612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of novel taspine derivatives as antiangiogenic agents.
    Zhang J; Zhang Y; Zhang S; Wang S; He L
    Bioorg Med Chem Lett; 2010 Jan; 20(2):718-21. PubMed ID: 20006929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphenylurea/thiourea derivatives tagged with heteroarylsulfonamide motifs as novel VEGFR2 inhibitors; Design, synthesis and anti-angiogenic activity.
    Al-Ansary GH; Nasr T; Taha H; Fayad W; Mahgoub S
    Bioorg Chem; 2021 Feb; 107():104640. PubMed ID: 33485105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationships of (aryloxy)quinazoline ureas as novel, potent, and selective vascular endothelial growth factor receptor-2 inhibitors.
    Garofalo A; Farce A; Ravez S; Lemoine A; Six P; Chavatte P; Goossens L; Depreux P
    J Med Chem; 2012 Feb; 55(3):1189-204. PubMed ID: 22229669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diarylureas and Diarylamides with Oxazolo[5,4-d]pyrimidine Scaffold as Angiogenesis Inhibitors.
    Deng YH; Liu JP; Cheng YJ; Liu Y; Sun LP
    Chem Biodivers; 2016 Sep; 13(9):1230-1239. PubMed ID: 27448711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl)-sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III.
    Xu F; Xu H; Wang X; Zhang L; Wen Q; Zhang Y; Xu W
    Bioorg Med Chem; 2014 Feb; 22(4):1487-95. PubMed ID: 24440479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity.
    Elsayed NMY; Serya RAT; Tolba MF; Ahmed M; Barakat K; Abou El Ella DA; Abouzid KAM
    Bioorg Chem; 2019 Feb; 82():340-359. PubMed ID: 30428414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2).
    Perspicace E; Jouan-Hureaux V; Ragno R; Ballante F; Sartini S; La Motta C; Da Settimo F; Chen B; Kirsch G; Schneider S; Faivre B; Hesse S
    Eur J Med Chem; 2013 May; 63():765-81. PubMed ID: 23583911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel VEGFR-2 inhibitors. Part II: biphenyl urea incorporated with salicylaldoxime.
    Gao H; Su P; Shi Y; Shen X; Zhang Y; Dong J; Zhang J
    Eur J Med Chem; 2015 Jan; 90():232-40. PubMed ID: 25461323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of novel vascular endothelial growth factor receptor 2 inhibitors: a virtual screening approach.
    Zhang L; Wang X; Feng J; Jia Y; Xu F; Xu W
    Chem Biol Drug Des; 2012 Dec; 80(6):893-901. PubMed ID: 22913881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel VEGFR-2 inhibitors. Part 5: Exploration of diverse hinge-binding fragments via core-refining approach.
    Shan Y; Gao H; Shao X; Wang J; Pan X; Zhang J
    Eur J Med Chem; 2015 Oct; 103():80-90. PubMed ID: 26342134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of 1,3-Diaryl-pyridones as Potent VEGFR-2 Inhibitors: Design, Synthesis, and Biological Evaluation.
    Yan W; Huang Z; Wang Z; Cao S; Tong L; Zhang T; Wang C; Zhou L; Ding J; Luo C; Zhou J; Xie H; Duan W
    Chem Biol Drug Des; 2016 May; 87(5):694-703. PubMed ID: 26669707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.